Position in ZVRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,976,380
+$2,904,007 QoQ
Shares Held
486,498
+11.3% QoQ
Ownership
0.819%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ZVRA ranks #136 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ZVRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,976,380 | 486,498 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,072,373 | 436,950 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,746,371 | 418,122 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,179,453 | 439,480 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,745,297 | 425,119 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,214,039 | 429,111 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,636,004 | 435,972 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,461,756 | 354,720 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,437,169 | 293,300 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,722,988 | 297,067 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,971,981 | 301,066 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,303,530 | 270,442 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,387,929 | 272,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $306,393 | 55,708 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $242,310 | 52,791 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $329,414 | 52,791 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $235,447 | 52,791 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,290,737 | 256,608 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,321,597 | 266,544 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,452,837 | 262,898 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,560,829 | 277,756 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $349,949 | 38,038 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||